Drug Type TCR therapy |
Synonyms DCTY 1102, DCTY1102 |
Target |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
KRAS G12D mutation Solid Tumors | IND Approval | CN | 09 Aug 2024 | |
Intestinal Neoplasms | IND Application | CN | - | |
Pancreatic Cancer | IND Application | CN | - |